January Durant

Also affiliated with Sinai Hospital, University of California San Diego, Canadian Apheresis Group, Alzheimer’s Disease Neuroimaging Initiative

MedicinePsychology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Varoglutamstat: Inhibiting Glutaminyl Cyclase as a Novel Target of Therapy in Early Alzheimer’s Disease”.

Varoglutamstat: Inhibiting Glutaminyl Cyclase as a Novel Target of Therapy in Early Alzheimer’s Disease

Journal of Alzheimer s Disease(2024)10.3233/jad-231126

N/A

0.522DataRank · unranked

17 citations

for the ADCS VIVA-MIND Study Group, Karen Messer, Yuqi Qiu, Marwan Sabbagh, Douglas Galasko +16 more

Protocol for a seamless phase 2A-phase 2B randomized double-blind placebo-controlled trial to evaluate the safety and efficacy of benfotiamine in patients with early Alzheimer’s disease (BenfoTeam)

PLoS ONE(2024)10.1371/journal.pone.0302998

N/A

0.319DataRank · unranked

4 citations

José A. Luchsinger, Gabriel C. Léger, Curtis Taylor, Diane M. Jacobs, David P. Salmon +15 more